93 related articles for article (PubMed ID: 11086958)
1. Introduction of the hematotoxicity modeling workshop.
Krewski D; Henry C
J Toxicol Environ Health A; 2000 Nov; 61(5-6):499-500. PubMed ID: 11086958
[No Abstract] [Full Text] [Related]
2. From cyclophosphamide hematotoxicity to modeling cancer.
Luebeck EG
J Toxicol Environ Health A; 2000 Nov; 61(5-6):515-20. PubMed ID: 11086961
[No Abstract] [Full Text] [Related]
3. A biomathematical model of cyclophosphamide hematotoxicity.
Cox LA
J Toxicol Environ Health A; 2000 Nov; 61(5-6):501-10. PubMed ID: 11086959
[No Abstract] [Full Text] [Related]
4. Comments on the Cox model of cyclophosphamide hematotoxicity.
Krishnan K
J Toxicol Environ Health A; 2000 Nov; 61(5-6):511-4. PubMed ID: 11086960
[No Abstract] [Full Text] [Related]
5. Biologically based risk assessment model for cyclophosphamide hematotoxicity in animal species: concluding comments.
Andersen ME; Krewski D
J Toxicol Environ Health A; 2000 Nov; 61(5-6):543-52. PubMed ID: 11086966
[No Abstract] [Full Text] [Related]
6. Comments on a biochemical model of cyclophosphamide hematotoxicity.
Portier CJ; Parham FM
J Toxicol Environ Health A; 2000 Nov; 61(5-6):525-8. PubMed ID: 11086963
[No Abstract] [Full Text] [Related]
7. Review of the Cox hematotoxicity model.
Heaney ML; Nimer SD
J Toxicol Environ Health A; 2000 Nov; 61(5-6):539-41. PubMed ID: 11086965
[No Abstract] [Full Text] [Related]
8. A clinician's comments on the cyclophosphamide hematotoxicity biologically based risk assessment model.
Atkins HL
J Toxicol Environ Health A; 2000 Nov; 61(5-6):529-38. PubMed ID: 11086964
[No Abstract] [Full Text] [Related]
9. Review of the Cox model.
Chen C
J Toxicol Environ Health A; 2000 Nov; 61(5-6):521-3. PubMed ID: 11086962
[No Abstract] [Full Text] [Related]
10. [Pharmacology of drugs impairing the hematopoietic system].
Bieroń K
Przegl Lek; 1971; 28(5):378-81. PubMed ID: 5091799
[No Abstract] [Full Text] [Related]
11. An application of a marked point process in pre-clinical medicine.
Berridge DM
Stat Med; 1996 Dec; 15(24):2751-62. PubMed ID: 8981684
[TBL] [Abstract][Full Text] [Related]
12. [Immunologic mechanisms in states of drug-induced impairment of the hematopoietic system].
Szmigiel Z
Przegl Lek; 1971; 28(5):382-4. PubMed ID: 5091800
[No Abstract] [Full Text] [Related]
13. [Experimental study on antineoplastic agents causing hematopoietic diseases].
Miyazaki S; Take H; Nagayama T
Nihon Shonika Gakkai Zasshi; 1972 Jan; 76(1):38-43. PubMed ID: 4112292
[No Abstract] [Full Text] [Related]
14. [Effect of lead on the hematopoietic system with reference to environmental and occupational exposure].
Lisiewicz J; Moszczyński P
Postepy Hig Med Dosw; 1986; 40(1):45-79. PubMed ID: 3532071
[No Abstract] [Full Text] [Related]
15. [Iatrogenic impairment of the hemopoietic system].
Aleksandrowicz J
Przegl Lek; 1971; 28(5):370-2. PubMed ID: 5091796
[No Abstract] [Full Text] [Related]
16. [Reconstitution of cyclophosphamide-induced, impaired function of the immune system in animal models].
Artym J
Postepy Hig Med Dosw; 2003; 57(1):55-66. PubMed ID: 12765123
[TBL] [Abstract][Full Text] [Related]
17. Hematologic side-effects of dapsone.
Wilson JR; Harris JW
Ohio State Med J; 1977 Aug; 73(8):557-60. PubMed ID: 887243
[No Abstract] [Full Text] [Related]
18. Hematologic side-effects of chloramphenicol.
Schröter W
Neuropadiatrie; 1974 May; 5(2):117-20. PubMed ID: 4601885
[No Abstract] [Full Text] [Related]
19. Drug-induced blood dyscrasias.
Bartos HR; Desforges JF
Practitioner; 1967 Jul; 199(189):37-45. PubMed ID: 6044117
[No Abstract] [Full Text] [Related]
20. Nonhuman primates in evaluation of hematotoxicity.
Saslaw S; Carlisle HN
Ann N Y Acad Sci; 1969 Jul; 162(1):646-58. PubMed ID: 4979575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
